Envoy Medical holders approve reverse split of 1-for-5 to 1-for-25 by Dec. 31, 2026

Envoy Medical, Inc.

At the Oct. 12, 2026 Special Meeting, stockholders approved amending the charter to let the board effect one or more reverse splits of Class A common stock at ratios from 1-for-5 to 1-for-25.
The reverse split authority expires on or before December 31, 2026, and any split is at the discretion of the Board of Directors.
Reverse Stock Split Proposal tallied 44,012,206 votes for, 50,668 against and 1,872 abstained.
The Adjournment Proposal passed 43,642,799 for, 406,221 against and 15,726 abstained; the adjournment authority was not used.
CEO Brent T. Lucas signed the report Oct. 16, 2026; Class A common stock trades as COCH and warrants as COCHW on Nasdaq.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.